• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复方口服避孕药对18岁以下女孩体重、身体成分、身高和骨密度的影响:一项系统评价

Combined oral contraceptives' influence on weight, body composition, height, and bone mineral density in girls younger than 18 years: a systematic review.

作者信息

Warholm Lina, Petersen Kresten R, Ravn Pernille

机构信息

University of Southern Denmark, Odense, Denmark.

出版信息

Eur J Contracept Reprod Health Care. 2012 Aug;17(4):245-53. doi: 10.3109/13625187.2012.692411. Epub 2012 Jul 3.

DOI:10.3109/13625187.2012.692411
PMID:22758931
Abstract

OBJECTIVE

Combined oral contraceptives (COCs) are increasingly used by adolescents. The aim of this review is to investigate the evidence regarding COCs' influence on weight, height and bone mineral density (BMD) in girls younger than 18 years.

METHOD

Systematic literature search using PubMed/Medline and Scopus (January 1990-February 2012) on COCs for girls under 18 years of age and the possible influence on body parameters. MeSH terms: Oral contraception; Adolescent; Weight; Body composition; Height; Bone mineral density.

RESULTS

There is no evidence that COCs induce weight gain in girls younger than 18 years. Obese girls are not at higher risk of gaining weight. COCs do not cause changes in body fat and lean mass beyond the changes caused by natural development. Moreover, growth and stature are unaffected. Few studies indicate that COCs have a negative impact on BMD, but the evidence is presently too limited for definite conclusions.

CONCLUSION

Studies in young users are few. Presently, there are no indications of a negative impact of COCs on weight, body composition or height. Lesser increases in BMD cannot be excluded. As the demand for COCs is increasing among the youngest girls, there is a need for prospective studies addressing this issue.

摘要

目的

青少年越来越多地使用复方口服避孕药(COC)。本综述的目的是调查有关COC对18岁以下女孩体重、身高和骨密度(BMD)影响的证据。

方法

利用PubMed/Medline和Scopus(1990年1月至2012年2月)对18岁以下女孩使用COC及其对身体参数可能产生的影响进行系统文献检索。医学主题词:口服避孕;青少年;体重;身体成分;身高;骨密度。

结果

没有证据表明COC会导致18岁以下女孩体重增加。肥胖女孩体重增加的风险并不更高。COC不会导致身体脂肪和瘦体重发生超出自然发育引起的变化。此外,生长和身高不受影响。少数研究表明COC对骨密度有负面影响,但目前证据过于有限,无法得出明确结论。

结论

针对年轻使用者的研究较少。目前,没有迹象表明COC会对体重、身体成分或身高产生负面影响。不能排除骨密度有较小增加的情况。由于最年轻女孩对COC的需求不断增加,有必要开展前瞻性研究来解决这一问题。

相似文献

1
Combined oral contraceptives' influence on weight, body composition, height, and bone mineral density in girls younger than 18 years: a systematic review.复方口服避孕药对18岁以下女孩体重、身体成分、身高和骨密度的影响:一项系统评价
Eur J Contracept Reprod Health Care. 2012 Aug;17(4):245-53. doi: 10.3109/13625187.2012.692411. Epub 2012 Jul 3.
2
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
3
Progestin-only contraceptives: effects on weight.仅含孕激素的避孕药:对体重的影响。
Cochrane Database Syst Rev. 2016 Aug 28;2016(8):CD008815. doi: 10.1002/14651858.CD008815.pub4.
4
Combined hormonal contraceptive use among breastfeeding women: an updated systematic review.哺乳期妇女联合使用激素避孕药:一项更新的系统评价。
Contraception. 2016 Sep;94(3):262-74. doi: 10.1016/j.contraception.2015.05.006. Epub 2015 May 19.
5
Hormonal contraception and bone metabolism: a systematic review.激素避孕与骨代谢:系统评价。
Contraception. 2012 Dec;86(6):606-21. doi: 10.1016/j.contraception.2012.04.009. Epub 2012 Jun 18.
6
Effectiveness and safety of vitamin D in relation to bone health.维生素D对骨骼健康的有效性与安全性。
Evid Rep Technol Assess (Full Rep). 2007 Aug(158):1-235.
7
Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.甾体避孕药:对非糖尿病女性碳水化合物代谢的影响
Cochrane Database Syst Rev. 2012 Apr 18(4):CD006133. doi: 10.1002/14651858.CD006133.pub4.
8
Nutritional interventions for survivors of childhood cancer.儿童癌症幸存者的营养干预措施。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD009678. doi: 10.1002/14651858.CD009678.pub2.
9
Psychological and/or educational interventions for the prevention of depression in children and adolescents.预防儿童和青少年抑郁症的心理和/或教育干预措施。
Cochrane Database Syst Rev. 2004(1):CD003380. doi: 10.1002/14651858.CD003380.pub2.
10
Combined oral contraceptive pills for treatment of acne.复方口服避孕药治疗痤疮。
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD004425. doi: 10.1002/14651858.CD004425.pub6.

引用本文的文献

1
EFFECT OF ORAL CONTRACEPTIVES ON BONE MINERAL DENSITY.口服避孕药对骨密度的影响。
Acta Endocrinol (Buchar). 2022 Jul-Sep;18(3):355-360. doi: 10.4183/aeb.2022.355.
2
Premature Ovarian Insufficiency and Bone Health Care: A Concern of the Gynecologist.卵巢早衰与骨骼健康护理:妇科医生的关注点。
Rev Bras Ginecol Obstet. 2018 Jun;40(6):305-308. doi: 10.1055/s-0038-1667112. Epub 2018 Jul 6.
3
The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations.
美国国家骨质疏松基金会关于峰值骨量发育与生活方式因素的立场声明:系统评价与实施建议
Osteoporos Int. 2016 Apr;27(4):1281-1386. doi: 10.1007/s00198-015-3440-3. Epub 2016 Feb 8.
4
Common Medications Which Lead to Unintended Alterations in Weight Gain or Organ Lipotoxicity.导致意外体重增加或器官脂毒性改变的常见药物。
Curr Gastroenterol Rep. 2016 Jan;18(1):2. doi: 10.1007/s11894-015-0479-4.
5
Steroidal contraceptives: effect on bone fractures in women.甾体避孕药:对女性骨折的影响
Cochrane Database Syst Rev. 2014 Jun 24;2014(6):CD006033. doi: 10.1002/14651858.CD006033.pub5.
6
A lower degree of PBMC L1 methylation is associated with excess body weight and higher HOMA-IR in the presence of lower concentrations of plasma folate.在血浆叶酸浓度较低的情况下,较低程度的 PBMC L1 甲基化与超重和更高的 HOMA-IR 相关。
PLoS One. 2013;8(1):e54544. doi: 10.1371/journal.pone.0054544. Epub 2013 Jan 24.